Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

3.57
Delayed Data
As of Apr 20
 0.00 / 0.00%
Today’s Change
3.44
Today|||52-Week Range
9.40
-22.73%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 15.50, with a high estimate of 20.00 and a low estimate of 10.00. The median estimate represents a +334.17% increase from the last price of 3.57.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.16
Sales
$9.5M
Reporting Date
May 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.67%
 
 
 
 
 
 
Growthannually -10.25%
 
 
 
 
 
 

Sales

Growthquarterly 7.90%
 
 
 
 
 
 
Growthannually 9.80%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.